CGP-53353

CAT: 0804-HY-108600-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-108600-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
CGP-53353 (DAPH-7) is an potent PKC inhibitor with IC50s of 0.41 μM and 3.8 μM for PKCβII and PKCβI, respectively. CGP-53353 can inhibit glucose-induced cell proliferation and DNA synthesis in AoSMC and A10 cells. CGP-53353 can be used for researching atherosclerosis of diabetic patients[1].
CAS Number
[145915-60-2]
Product Name Alternative
DAPH-7
UNSPSC
12352005
Target
DNA/RNA Synthesis; PKC
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics; TGF-beta/Smad
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/cgp-53353.html
Concentration
10mM
Purity
98.87
Solubility
DMSO : ≥ 50 mg/mL
Smiles
O=C1NC(C2=C1C=C(NC3=CC=C(F)C=C3)C(NC4=CC=C(F)C=C4)=C2)=O
Molecular Formula
C20H13F2N3O2
Molecular Weight
365.33
References & Citations
[1]Yamamoto M, et al. Acute glucose-induced downregulation of PKC-betaII accelerates cultured VSMC proliferation. Am J Physiol Cell Physiol. 2000;279 (3) :C587-C595.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PKCβ

Related Products

CatalogName
HY-19054-01CGP-20376
HY-111528CGP 43487
HY-121599-01CGP 36742
HY-100454-01CGP 25454A
HY-129563CGP 57813
HY-123602CGP 55802A
HY-121099Cgp 8065
HY-120192CGP 62349
HY-19061CGP 28014
HY-117559CGP-75355

Alternative Products

CatalogName
2442/10CGP 53353
M11980-01CGP-53353
217271CGP 35348 (GABAB Receptor Antagonist, CGP 35348, CGP35348, CGP-35348)
MBS3604843-01CGP 57380
MBS3844893-01CGP 25454A
M36843-01CGP 37849
M34544-01CGP 20376
MBS387469-01CGP-52411
M12989-01CGP-74514A
MDP0668CGP 42112

Popular Products